{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:51:42Z","timestamp":1793389902190,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:00:00Z","timestamp":1728259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004590","name":"Central Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijcard.2024.132613","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T15:56:53Z","timestamp":1728143813000},"page":"132613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI"],"prefix":"10.1016","volume":"418","author":[{"given":"Sindre","family":"Woxholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kristine","family":"Anstensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild Maria","family":"T\u00f8llefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingebj\u00f8rg","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuva B.","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir \u00d8ystein","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Wiseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Kristian","family":"Dam\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Kleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ijcard.2024.132613_bb0005","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132613_bb0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1042\/CS20180306","article-title":"Atherosclerosis and inflammation: overview and updates","volume":"132","author":"Geovanini","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ijcard.2024.132613_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"15","key":"10.1016\/j.ijcard.2024.132613_bb0020","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of Interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2024.132613_bb0025","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/erc.10.92","article-title":"Activated platelets and atherosclerosis","volume":"8","author":"Aukrust","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132613_bb0030","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk","volume":"28","author":"Aukrust","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijcard.2024.132613_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132613_bb0040","first-page":"841","article-title":"Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets","volume":"27","author":"Marino","year":"2013","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"3","key":"10.1016\/j.ijcard.2024.132613_bb0045","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jacbts.2020.12.009","article-title":"Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients","volume":"6","author":"Canzano","year":"2021","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2024.132613_bb0050","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/09537104.2019.1609665","article-title":"The in vitro effect of antirheumatic drugs on platelet function","volume":"31","author":"Nielsen","year":"2020","journal-title":"Platelets"},{"key":"10.1016\/j.ijcard.2024.132613_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2020.10.020","article-title":"Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19","volume":"83","author":"Di Nisio","year":"2021","journal-title":"Eur. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132613_bb0060","doi-asserted-by":"crossref","first-page":"10647","DOI":"10.1038\/s41598-018-29026-0","article-title":"Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis","volume":"8","author":"Vajen","year":"2018","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.ijcard.2024.132613_bb0065","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.jacc.2009.12.037","article-title":"Microvascular obstruction: underlying pathophysiology and clinical diagnosis","volume":"55","author":"Bekkers","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2024.132613_bb0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jacc.2006.06.060","article-title":"Increased levels of neutrophil-activating Peptide-2 in acute coronary syndromes","volume":"48","author":"Smith","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2024.132613_bb0075","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/jth.12404","article-title":"Platelet-derived CXCL12 (SDF-1\u03b1): basic mechanisms and clinical implications","volume":"11","author":"Chatterjee","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.ijcard.2024.132613_bb0080","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/carcin\/bgn045","article-title":"Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells","volume":"29","author":"Tang","year":"2008","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132613_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2342-10-1","article-title":"Design and validation of segment - freely available software for cardiovascular image analysis","volume":"10","author":"Heiberg","year":"2010","journal-title":"BMC Med. Imaging"},{"issue":"11","key":"10.1016\/j.ijcard.2024.132613_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111805","article-title":"Microvascular obstruction in ST-segment elevation myocardial infarction: looking back to move forward. Focus on CMR","volume":"8","author":"Rios-Navarro","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132613_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104013","article-title":"Interleukin-6 inhibition in ST-elevation myocardial infarction: immune cell profile in the randomised ASSAIL-MI trial","volume":"80","author":"Huse","year":"2022","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132613_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002301","article-title":"Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab","volume":"10","author":"Woxholt","year":"2023","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132613_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/01.CIR.0000020001.09990.90","article-title":"Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects","volume":"106","author":"Dam\u00e5s","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132613_bb0110","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/ATVBAHA.112.301162","article-title":"CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice","volume":"33","author":"Akhtar","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132613_bb0115","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1194\/jlr.RA119000100","article-title":"CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4\/GSK3\u03b2\/\u03b2-catenin(T120)\/TCF21 pathway","volume":"60","author":"Gao","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2024.132613_bb0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2014.04.021","article-title":"CXCR4 blockade induces atherosclerosis by affecting neutrophil function","volume":"74","author":"Bot","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2024.132613_bb0125","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/CIRCULATIONAHA.118.037953","article-title":"CXCL12 derived from endothelial cells promotes atherosclerosis to drive coronary artery disease","volume":"139","author":"D\u00f6ring","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2024.132613_bb0130","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/pro.167","article-title":"Monomeric structure of the cardioprotective chemokine SDF-1\/CXCL12","volume":"18","author":"Veldkamp","year":"2009","journal-title":"Protein Sci."},{"issue":"9_Part_1","key":"10.1016\/j.ijcard.2024.132613_bb0135","doi-asserted-by":"crossref","first-page":"101193","DOI":"10.1016\/j.jacadv.2024.101193","article-title":"Neutrophil extracellular traps in ST-segment elevation myocardial infarction","volume":"3","author":"Kindberg","year":"2024","journal-title":"JACC Adv."},{"issue":"43","key":"10.1016\/j.ijcard.2024.132613_bb0140","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1074\/jbc.RA119.009879","article-title":"Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate","volume":"294","author":"Sepuru","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132613_bb0145","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/CIRCULATIONAHA.106.631457","article-title":"Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells","volume":"114","author":"Ranjbaran","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2024.132613_bb0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1074\/jbc.M112.394064","article-title":"Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus","volume":"288","author":"Ziarek","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijcard.2024.132613_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191303","article-title":"The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation","volume":"13","author":"Ponert","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ijcard.2024.132613_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1165\/rcmb.2013-0485TR","article-title":"Complement system in lung disease","volume":"51","author":"Pandya","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"12","key":"10.1016\/j.ijcard.2024.132613_bb0165","doi-asserted-by":"crossref","first-page":"C1184","DOI":"10.1152\/ajpcell.00269.2013","article-title":"Heparanase induces inflammatory cell recruitment in vivo by promoting adhesion to vascular endothelium","volume":"306","author":"Lever","year":"2014","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"4","key":"10.1016\/j.ijcard.2024.132613_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040584","article-title":"Heparin, low molecular weight heparin, and non-anticoagulant derivatives for the treatment of inflammatory lung disease","volume":"16","author":"Shute","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.ijcard.2024.132613_bb0175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel","volume":"74","author":"Ibanez","year":"2019","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732401235X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752732401235X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T21:12:11Z","timestamp":1737580331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752732401235X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"alternative-id":["S016752732401235X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132613","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"132613"}}